| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.145 | 8.527 | 16.379 | 11.259 | 15.639 | 11.030 | 13.050 | 11.115 | 10.846 | 8.926 |
| Total Income - EUR | 8.145 | 8.527 | 16.379 | 11.259 | 15.639 | 11.030 | 13.051 | 11.118 | 10.846 | 8.926 |
| Total Expenses - EUR | 876 | 201 | 533 | 3.210 | 341 | 6.614 | 493 | 2.034 | 7.922 | 4.935 |
| Gross Profit/Loss - EUR | 7.269 | 8.326 | 15.846 | 8.049 | 15.298 | 4.415 | 12.558 | 9.083 | 2.924 | 3.991 |
| Net Profit/Loss - EUR | 7.025 | 8.070 | 15.355 | 7.711 | 14.828 | 4.085 | 12.166 | 8.750 | 2.456 | 3.291 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mediplus Am S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.206 | 1.194 | 1.173 | 1.152 | 1.130 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 24.486 | 32.517 | 47.665 | 54.062 | 68.312 | 72.541 | 83.282 | 11.620 | 11.698 | 19.113 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 22.016 | 2.321 | 5.226 | 6.655 | 11.687 | 7.284 | 9.438 | 1.615 | 0 | 1.435 |
| Cash | 2.471 | 30.196 | 42.440 | 47.407 | 56.625 | 65.257 | 73.843 | 10.005 | 11.698 | 17.677 |
| Shareholders Funds | 25.593 | 33.402 | 48.192 | 55.018 | 68.781 | 71.562 | 82.141 | 8.468 | 10.899 | 14.129 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 99 | 309 | 647 | 195 | 661 | 979 | 1.141 | 3.151 | 799 | 4.984 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Mediplus Am S.r.l.